🧐 ProPicks AI October update is out now! See which stocks made the listPick Stocks with AI

Walmart unit Sam's Club partners with DoorDash to deliver medicines

Published 2020-10-30, 08:06 a/m
© Reuters. Trailers bearing the Walmart and Sam's Club logos are seen outside Walmart Distribution Center 6025 as the coronavirus disease (COVID-19) outbreak continues in Menomonie
WMT
-
M
-

(Reuters) - Warehouse chain Sam's Club, a unit of Walmart (NYSE:WMT) Inc, said on Friday it will provide prescribed medicines to patients through delivery firm DoorDash Inc, as customers turn to digital orders during the COVID-19 pandemic.

DoorDash will deliver items from more than 500 Sam's Club pharmacies and patients can call the pharmacies to schedule a same-day delivery, the warehouse club operator said.

Demand for online delivery, ranging from meal kits to sporting goods, has soared during the outbreak, as stay-at-home consumers increasingly prefer having items delivered at their doorsteps due to fears of contracting the virus.

Patients can buy prescribed medications from Sam's Club without a membership, according to the club operator's website.

"Businesses have evolved amid the pandemic to prioritize the safety of their communities and to adapt to new consumer habits," DoorDash Chief Operating Officer Christopher Payne said.

San Francisco, California-based DoorDash, popular for its food delivery service, has also been branching out to tap a surge in online shopping during the health crisis. The company has recently partnered with department-store operator Macy's Inc (NYSE:M), pet products retailer PetSmart Inc and grocer Meijer Inc, among other big names.

© Reuters. Trailers bearing the Walmart and Sam's Club logos are seen outside Walmart Distribution Center 6025 as the coronavirus disease (COVID-19) outbreak continues in Menomonie

Overall online sales at Sam's Club jumped 39% in the second quarter ended July 31, compared with Walmart's whopping 97% surge in the United States.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.